X
Scotland says no to Yescarta, but backs Kymriah
https://pharmaphorum.com/news/scotland-says-no-to-yescarta-but-backs-kymriah/
SMC
AZ’s Tagrisso gets NHS funding in Scotland
SMC backs drug based on feedback from patients and doctors, after rejection by NICE.
Myeloma drugs Darzalex and Kyprolis rejected in Scotland
SMC says “no” to Amgen and Janssen multiple myeloma drugs.
Doubts over future of rare drug fund in Scotland
Funding could be unsustainable, says review.
Scotland to fund BMS skin cancer combo
Patient evidence convinces SMC Opdivo+Yervoy is cost-effective.
Scotland’s Opdivo decision sparks funding row
Patients in Scotland will receive lung cancer drug, those in England will not.
